Litcius/Paper detail

Bioengineered metastatic cancer nanovaccine with a TLR7/8 agonist for needle-free intranasal immunization

Jae Min Jung, Min Sang Lee, Young Kyu Seo, Jung Eun Lee, Su Yeon Lim, Da Kim, Su Yeon Lim, Chaeeun Park, Byung Deok Kim, Ju Hwa Shin, Ji Hyun Lee, Liu Pin, Ji Hyun Lee, João Conde, Thavasyappan Thambi, Ji Hoon Jeong, João Conde, Thavasyappan Thambi, Ji Hoon Jeong, Thavasyappan Thambi

2025Biomaterials8 citationsDOI

Topics & Concepts

Nasal administrationTLR7ImmunizationAgonistCancerMaterials scienceCancer researchBiomedical engineeringPharmacologyMedicineImmunologyInternal medicineReceptorImmune systemInnate immune systemToll-like receptorImmunotherapy and Immune ResponsesCancer Research and TreatmentsAntimicrobial Peptides and Activities
Bioengineered metastatic cancer nanovaccine with a TLR7/8 agonist for needle-free intranasal immunization | Litcius